Clinico-Radiological Correlation in Children with Ataxia Telangiectasia in Qatar


Introduction: Ataxia telangiectasia (AT) is a rare disease characterized by immunodeficiency and neurological manifestations. Ataxia, resulting from cerebella atrophy, runs a progressive incapacitating course. Clinical monitoring of the disease course is mandatory for early treatment. Aim: To study clinical severity of AT and correlate it with the degree of cerebellar atrophy. Patients and Methods: We retrospectively studied all children (less than 14 years) with AT seen at Hamad General Hospital Clinics between 1998-2013. We collected basic demographic data, parental consan-guinity, family history, AT clinical severity scores, and reviewed CBC with differential counts; alpha-fetoprotein, serum immunoglobulins and lymphocyte subsets. Cranial MRI scans of each subject were reviewed by a neuroradiologist. Cerebellar atrophy was visually and semi-quantitatively scored. Results: We analyzed data on 18 AT children (10 males and 8 females), mean age of 76.9 months. 77.8% had a positive family history of AT and 41.7% parental consanguinity. Lymphopenia was observed in 77.8% and high serum alpha-fetoprotein in 87.5% of children. Clinical severity of ataxia was 17.1 ± 8.4 (mean ± SD); 86.7% of patients were moderate-severe. MRI cerebellar atrophy score was 1.9 ± 1.3 (mean ± SD), and moderate in 51% of patients. AT clinical severity score correlated (coefficient r = 0.566) but not statistically significant p = 0.088) with MRI cerebellar atrophy scores. Conclusions: Moderate to severe ataxia and marked cerebellar atrophy are quite common in AT children. There is a correlation between AT clinical severity and cerebellar atrophy. Larger prospective studies might further determine the significance of our observations and help practicing practitioners monitor the progression of the disease.

Share and Cite:

Ehlayel, M. , Elsaid, M. , Shami, R. , Salem, K. and Bener, A. (2015) Clinico-Radiological Correlation in Children with Ataxia Telangiectasia in Qatar. Open Journal of Immunology, 5, 33-38. doi: 10.4236/oji.2015.51004.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Rezaei, N., Bonilla, F.A., Sullivan, K.E., de Vries, E. and Orange, J.S. (2008) Chapter 1. An Introduction to Primary Immunodeficiency Diseases. In: Rezaei, N., Aghamohammadi, A. and Notarangelo, L.D., Eds., Primary Immunodeficiency Diseases, Definition Diagnosis and Management, Springer-Verlag, Berlin, 1-38.
[2] (2013) OMIM ATM: 208900.
[3] Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D.A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S.R., Simmons, A., Clines, G.A., Sartiel, A., Gatti, R.A., Chessa, L., Sanal, O., Lavin, M.F., Jaspers, N.G., Taylor, A.M., Arlett, C.F., Miki, T., Weissman, S.M., Lovett, M., Collins, F.S. and Shiloh, Y. (1995) A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase. Science, 268, 1749-1753.
[4] Hoche, F., Seidel, K., Theis, M., Vlaho, S., Schubert, R., Zielen, S. and Kieslich, M. (2012) Neurodegeneration in Ataxia Telangiectasia: What Is New? What Is Evident? Neuropediatrics, 43, 119-129.
[5] Gilad, S., Chessa, L., Khosravi, R., Russell, P., Galanty, Y., Piane, M., Gatti, R.A., Jorgensen, T.J., Shiloh, Y. and Bar-Shira, A. (1998) Genotype-Phenotype Relationships in Ataxia-Telangiectasia and Variants. American Journal of Human Genetics, 62, 551-561.
[6] Becker-Catania, S.G., Chen, G., Hwang, M.J., Wang, Z., Sun, X., Sanal, O., Bernatowska-Matuszkiewicz, E., Chessa, L., Lee, E.Y. and Gatti, R.A. (2000) Ataxia-Telangiectasia: Phenotype/Genotype Studies of ATM Protein Expression, Mutations, and Radiosensitivity. Molecular Genetics and Metabolism, 70, 122-133.
[7] Verhagen, M.M., Last, J.I., Hogervorst, F.B., Smeets, D.F., Roeleveld, N., Verheijen, F., Catsman-Berrevoets, C.E., Wulffraat, N.M., Cobben, J.M., Hiel, J., Brunt, E.R., Peeters, E.A., Gomez Garcia, E.B., van der Knaap, M.S., Lincke, C.R., Laan, L.A., Tijssen, M.A., van Rijn, M.A., Majoor-Krakauer, D., Visser, M., van’t Veer, L.J., Kleijer, W.J., van de Warrenburg, B.P., Warris, A., de Groot, I.J., de Groot, R., Broeks, A., Preijers, F., Kremer, B.H., Weemaes, C.M., Taylor, M.A., van Deuren, M. and Willemsen, M.A. (2012) Presence of ATM Protein and Residual Kinase Activity Correlates with the Phenotype in Ataxia-Telangiectasia: A Genotype-Phenotype Study. Human Mutation, 33, 561-571.
[8] Spacey, S.D., Gatti, R.A. and Bebb, G. (2000) The Molecular Basis and Clinical Management of Ataxia Telangiectasia. Canadian Journal of Neurological Sciences, 27, 184-191.
[9] Fatterpekar, G., Naidich, T.P. and Som, P.M. (2012) The Teaching Files: Brain and Spine Imaging. Elsevier Health Sciences, 102-103.
[10] Meshram, C.M., Sawhney, I.M.S., Prabhakar, S. and Chopra, J.S. (1986) Ataxia Telangiectasia in Identical Twins: Unusual Features. Journal of Neurology, 233, 304-305.
[11] Lin, D.D.M., Barker, P.B., Lederman, H.M. and Crawford, T.O. (2014) Cerebral Abnormalities in Adults with Ataxia-Telangiectasia. American Journal of Neuroradiology, 35, 119-123.
[12] Sahama, I., Sinclair, K., Pannek, K., Lavin, M. and Rose, S. (2014) Radiological Imaging in Ataxia Telangiectasia: A Review. The Cerebellum, 13, 521-530.
[13] Volkow, N.D., Tomasi, D., Wang, G.J., Studentsova, Y., Margus, B. and Crawford, T.O. (2014) Brain Glucose Metabolism in Adults with Ataxia-Telangiectasia and Their Asymptomatic Relatives. Brain, 137, 1753-1761.
[14] Schmitz-Hubsch, T., du Montcel, S.T., Baliko, L., Berciano, J., Boesch, S., Depondt, C., Giunti, P., Globas, C., Infante, J., Kang, J.S., Kremer, B., Mariotti, C., Melegh, B., Pandolfo, M., Rakowicz, M., Ribai, P., Rola, R., Schols, L., Szymanski, S., van de Warrenburg, B.P., Durr, A., Klockgether, T. and Fancellu, R. (2006) Scale for the Assessment and Rating of Ataxia: Development of a New Clinical Scale. Neurology, 66, 1717-1720.
[15] Saviozzi, S., Saluto, A., Taylor, A.M., Last, J.I., Trebini, F., Paradiso, M.C., Grosso, E., Funaro, A., Ponzio, G., Migone, N. and Brusco, A. (2002) A Late Onset Variant of Ataxia-Telangiectasia with a Compound Heterozygous Genotype, A8030G/7481insA. Journal of Medical Genetics, 39, 57-61.
[16] Sutton, I.J., Last, J.I., Ritchie, S.J., Harrington, H.J., Byrd, P.J. and Taylor, A.M. (2004) Adult-Onset Ataxia Telangiectasia Due to ATM 5762ins137 Mutation Homozygosity. Annals of Neurology, 55, 891-895.
[17] Burk, K., Schulz, S.R. and Schulz, J.B. (2013) Monitoring Progression in Friedreich Ataxia (FRDA): The Use of Clinical Scales. Journal of Neurochemistry, 126, 118-124.
[18] Crawford, T.O., Mandir, A.S., Lefton-Greif, M.A., Goodman, S.N., Goodman, B.K., Sengul, H. and Lederman, H.M. (2000) Quantitative Neurologic Assessment of Ataxia-Telangiectasia. Neurology, 54, 1505-1509.
[19] Schmitz-Hubsch, T., Tezenas du Montcel, S., Baliko, L., Boesch, S., Bonato, S., Fancellu, R., Giunti, P., Globas, C., Kang, J.S., Kremer, B., Mariotti, C., Melegh, B., Rakowicz, M., Rola, R., Romano, S., Schols, L., Szymanski, S., van de Warrenburg, B.P., Zdzienicka, E., Durr, A. and Klockgether, T. (2006) Reliability and Validity of the International Cooperative Ataxia Rating Scale: A Study in 156 Spinocerebellar Ataxia Patients. Movement Disorders, 21, 699-704.
[20] International Cooperative Ataxia Rating Scale.
[21] Saute, J.A., Donis, K.C., Serrano-Munuera, C., Genis, D., Ramirez, L.T., Mazzetti, P., Perez, L.V., Latorre, P., Sequeiros, J., Matilla-Duenas, A. and Jardim, L.B. (2012) Ataxia Rating Scales—Psychometric Profiles, Natural History and Their Application in Clinical Trials. The Cerebellum, 11, 488-504.
[22] Schmahmann, J.D., Gardner, R., MacMore, J. and Vangel, M.G. (2009) Development of a Brief Ataxia Rating Scale (BARS) Based on a Modified Form of the ICARS. Movement Disorders, 24, 1820-1828.
[23] Brandsma, R., Spits, A.H., Kuiper, M.J., Lunsing, R.J., Burger, H., Kremer, H.P. and Sival, D.A. (2014) Ataxia Rating Scales Are Age-Dependent in Healthy Children. Developmental Medicine & Child Neurology, 56, 556-563.
[24] Sardanelli, F., Parodi, R.C., Ottonello, C., Renzetti, P., Saitta, S., Lignana, E. and Mancardi, G.L. (1995) Cranial MRI in Ataxia-Telangiectasia. Neuroradiology, 37, 77-82.
[25] Currie, S., Hadjivassiliou, M., Craven, I.J., Wilkinson, I.D., Griffiths, P.D. and Hoggard, N. (2013) Magnetic Resonance Imaging Biomarkers in Patients with Progressive Ataxia: Current Status and Future Direction. The Cerebellum, 12, 245-266.
[26] Baldarcara, L., Currie, S., Hadjivassiliou, M., Hoggard, N., Jack, A., Jackowski, A.P., Mascalchi, M., Parazzini, C., Reetz, K., Righini, A., Schulz, J.B., Vella, A., Webb, S.J. and Habas, C. (2014) Consensus Paper: Radiological Biomarkers of Cerebellar Diseases. Cerebellum, 14, 175-196.
[27] Wallis, L.I., Griffiths, P.D., Ritchie, S.J., Romanowski, C.A., Darwent, G. and Wilkinson, I.D. (2007) Proton Spectroscopy and Imaging at 3T in Ataxia-Telangiectasia. American Journal of Neuroradiology, 28, 79-83.
[28] Ministry of Development, Planning, and Statistics (2013) Qatar Information Exchange.
[29] Genetics Home Reference (2014) Ataxia-Telangiectasia.
[30] Ehlayel, M., Bener, A. and Abu Laban, M. (2013) Effects of Family History and Consanguinity in Primary Immunodeficiency Diseases in Children in Qatar. Open Journal of Immunology, 3, 47-53.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.